About the Innovative Clinical Trial Designs in Oncology Session
Innovative clinical trial designs in oncology are essential for advancing cancer treatments and improving patient outcomes. Traditional clinical trial models can be time-consuming and costly, often failing to account for the diverse genetic and environmental factors that influence cancer progression. In response, researchers are developing more adaptive and flexible trial designs, such as basket trials, umbrella trials, and platform trials. These approaches allow for the evaluation of multiple treatments across various cancer types, improving efficiency and enabling the rapid identification of effective therapies. Additionally, incorporating biomarkers into trial designs can ensure that patients receive treatments tailored to their specific genetic profiles. These innovative clinical trial designs not only accelerate the development of new cancer treatments but also ensure that they are more effective and personalized.
Topics Covered in Innovative Clinical Trial Designs in Oncology
Basket Trials
Umbrella Trials
Platform Trials
Adaptive Randomization
Synthetic Control Arms
Decentralized Trials
Related Scientific Sessions at CIOC 2027
Why Attend the Innovative Clinical Trial Designs in Oncology Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Innovative Clinical Trial Designs in Oncology work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Innovative Clinical Trial Designs in Oncology research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Innovative Clinical Trial Designs in Oncology track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Innovative Clinical Trial Designs in Oncology Conference 2027 — FAQs
What is the Innovative Clinical Trial Designs in Oncology track at CIOC 2027?
The Innovative Clinical Trial Designs in Oncology track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Innovative Clinical Trial Designs in Oncology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Innovative Clinical Trial Designs in Oncology sessions?
Cancer researchers and clinicians, educators and students with an interest in Innovative Clinical Trial Designs in Oncology are all welcome — whether presenting or attending.
Can I present my research in the Innovative Clinical Trial Designs in Oncology track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Innovative Clinical Trial Designs in Oncology sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Innovative Clinical Trial Designs in Oncology track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.